BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9648876)

  • 21. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis.
    Menzies FM; Grierson AJ; Cookson MR; Heath PR; Tomkins J; Figlewicz DA; Ince PG; Shaw PJ
    J Neurochem; 2002 Sep; 82(5):1118-28. PubMed ID: 12358759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
    Ihara Y; Nobukuni K; Takata H; Hayabara T
    Neurol Res; 2005 Jan; 27(1):105-8. PubMed ID: 15829169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients.
    Hoyaux D; Boom A; Van den Bosch L; Belot N; Martin JJ; Heizmann CW; Kiss R; Pochet R
    J Neuropathol Exp Neurol; 2002 Aug; 61(8):736-44. PubMed ID: 12152788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses.
    Liochev SI; Fridovich I
    Free Radic Biol Med; 2003 Jun; 34(11):1383-9. PubMed ID: 12757848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
    Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity.
    Yamashita S; Mori A; Kimura E; Mita S; Maeda Y; Hirano T; Uchino M
    J Neurochem; 2010 May; 113(4):860-70. PubMed ID: 20202083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal model.
    Okamoto Y; Shirakashi Y; Ihara M; Urushitani M; Oono M; Kawamoto Y; Yamashita H; Shimohama S; Kato S; Hirano A; Tomimoto H; Ito H; Takahashi R
    PLoS One; 2011; 6(5):e20427. PubMed ID: 21655264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
    Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
    Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
    Yim MB; Kang JH; Yim HS; Kwak HS; Chock PB; Stadtman ER
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5709-14. PubMed ID: 8650157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
    Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
    J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
    Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
    Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis.
    Fiszman ML; Borodinsky LN; Ricart KC; Sanz OP; Sica RE
    J Neurol Sci; 1999 Jan; 162(1):34-7. PubMed ID: 10064166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers.
    Debska-Vielhaber G; Miller I; Peeva V; Zuschratter W; Walczak J; Schreiber S; Petri S; Machts J; Vogt S; Szczepanowska J; Gellerich FN; Hermann A; Vielhaber S; Kunz WS
    Exp Neurol; 2021 May; 339():113620. PubMed ID: 33497646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.
    Wicks P; Abrahams S; Papps B; Al-Chalabi A; Shaw CE; Leigh PN; Goldstein LH
    J Neurol; 2009 Feb; 256(2):234-41. PubMed ID: 19252762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.
    Battistini S; Giannini F; Greco G; Bibbò G; Ferrera L; Marini V; Causarano R; Casula M; Lando G; Patrosso MC; Caponnetto C; Origone P; Marocchi A; Del Corona A; Siciliano G; Carrera P; Mascia V; Giagheddu M; Carcassi C; Orrù S; Garrè C; Penco S
    J Neurol; 2005 Jul; 252(7):782-8. PubMed ID: 15789135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinesin expression in the central nervous system of humans and transgenic hSOD1G93A mice with amyotrophic lateral sclerosis.
    Kuźma-Kozakiewicz M; Chudy A; Gajewska B; Dziewulska D; Usarek E; Barańczyk-Kuźma A
    Neurodegener Dis; 2013; 12(2):71-80. PubMed ID: 23006449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis.
    Gruzman A; Wood WL; Alpert E; Prasad MD; Miller RG; Rothstein JD; Bowser R; Hamilton R; Wood TD; Cleveland DW; Lingappa VR; Liu J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12524-9. PubMed ID: 17636119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.